These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9548327)

  • 1. Neuroblastoma in an adult with a high serum level of carbohydrate antigen, CA125: report of a case.
    Hirokawa S; Yamashita I; Kuroki Y; Yamashita Y; Fujimaki M; Aoyama K; Murakami J
    Surg Today; 1998; 28(3):349-54. PubMed ID: 9548327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
    Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
    Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxedema ascites with an extremely elevated CA125 Level: a case report.
    Kanehara H; Bando Y; Tomita M; Kontani M; Takegoshi Y; Tanaka N
    Endocr J; 2007 Aug; 54(4):601-4. PubMed ID: 17641444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of primary peritoneal carcinoma successfully treated using Paclitaxel and Carboplatin chemotherapy].
    Takagi K; Tamura A; Hayasaka J; Watanabe A; Okamoto E; Kusano-Kitazume A; Kondo M; Shibayama T; Suenobu Y; Ohtaka Y; Akita H; Tei S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2490-2. PubMed ID: 25731567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study.
    van Altena AM; Kolwijck E; Spanjer MJ; Hendriks JC; Massuger LF; de Hullu JA
    Gynecol Oncol; 2010 Nov; 119(2):265-9. PubMed ID: 20797777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
    von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
    J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of serum CA(125) detection for predicting recurrence and prognosis in ovarian epithelial cancer].
    Wang XY; Ye J; Feng SW; Lü WG; Wan XY; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):813-6. PubMed ID: 21211277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
    Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
    J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer.
    Le T; Faught W; Hopkins L; Fung-Kee-Fung M
    J Obstet Gynaecol Can; 2008 Aug; 30(8):665-670. PubMed ID: 18786288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    J Clin Oncol; ; . PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.